These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 2521520)
1. Cross-resistance to the lipid-soluble antifolate trimetrexate in human carcinoma cells with the multidrug-resistant phenotype. Assaraf YG; Molina A; Schimke RT J Natl Cancer Inst; 1989 Feb; 81(4):290-4. PubMed ID: 2521520 [TBL] [Abstract][Full Text] [Related]
2. A phenotype conferring selective resistance to lipophilic antifolates in Chinese hamster ovary cells. Sharma RC; Assaraf YG; Schimke RT Cancer Res; 1991 Jun; 51(11):2949-59. PubMed ID: 1674447 [TBL] [Abstract][Full Text] [Related]
3. Sequential amplification of dihydrofolate reductase and multidrug resistance genes in Chinese hamster ovary cells selected for stepwise resistance to the lipid-soluble antifolate trimetrexate. Assaraf YG; Molina A; Schimke RT J Biol Chem; 1989 Nov; 264(31):18326-34. PubMed ID: 2572592 [TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate. Arkin H; Ohnuma T; Kamen BA; Holland JF; Vallabhajosula S Cancer Res; 1989 Dec; 49(23):6556-61. PubMed ID: 2573416 [TBL] [Abstract][Full Text] [Related]
5. Flow cytometric characterization of antifolate resistance in cultured mammalian cells using fluoresceinated methotrexate and daunorubicin. Sherwood SW; Assaraf YG; Molina A; Schimke RT Cancer Res; 1990 Aug; 50(16):4946-50. PubMed ID: 2143099 [TBL] [Abstract][Full Text] [Related]
6. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate. Takemura Y; Ohnuma T Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841 [TBL] [Abstract][Full Text] [Related]
7. Characterization of trimetrexate transport in human lymphoblastoid cells and development of impaired influx as a mechanism of resistance to lipophilic antifolates. Fry DW; Besserer JA Cancer Res; 1988 Dec; 48(24 Pt 1):6986-91. PubMed ID: 2973370 [TBL] [Abstract][Full Text] [Related]
8. Differential reversal of lipophilic antifolate resistance in mammalian cells with modulators of the multidrug resistance phenotype. Assaraf YG; Borgnia MJ Anticancer Drugs; 1993 Jun; 4(3):395-406. PubMed ID: 8102912 [TBL] [Abstract][Full Text] [Related]
9. Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate. Schwartz GK; Arkin H; Holland JF; Ohnuma T Cancer Res; 1991 Jan; 51(1):55-61. PubMed ID: 1824824 [TBL] [Abstract][Full Text] [Related]
10. Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate. Fanin R; Banerjee D; Volkenandt M; Waltham M; Li WW; Dicker AP; Schweitzer BI; Bertino JR Mol Pharmacol; 1993 Jul; 44(1):13-21. PubMed ID: 8341268 [TBL] [Abstract][Full Text] [Related]
11. Biochemical pharmacology of the lipophilic antifolate, trimetrexate. Jackson RC; Fry DW; Boritzki TJ; Besserer JA; Leopold WR; Sloan BJ; Elslager EF Adv Enzyme Regul; 1984; 22():187-206. PubMed ID: 6236675 [TBL] [Abstract][Full Text] [Related]
12. Characterization by flow cytometry and fluorescein-methotrexate labeling of hydrophilic and lipophilic antifolate resistance in cultured mammalian cells. Assaraf YG Anticancer Drugs; 1993 Oct; 4(5):535-44. PubMed ID: 8292810 [TBL] [Abstract][Full Text] [Related]
13. A human leukemia cell line made resistant to two folate analogues, trimetrexate and N10-propargyl-5,8-dideazafolic acid (CB3717). Takemura Y; Ohnuma T; Miyachi H; Sekiguchi S J Cancer Res Clin Oncol; 1991; 117(6):519-25. PubMed ID: 1683871 [TBL] [Abstract][Full Text] [Related]
14. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate. Diddens H; Niethammer D; Jackson RC Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514 [TBL] [Abstract][Full Text] [Related]
15. Inherent resistance of human squamous carcinoma cell lines to methotrexate as a result of decreased polyglutamylation of this drug. Pizzorno G; Chang YM; McGuire JJ; Bertino JR Cancer Res; 1989 Oct; 49(19):5275-80. PubMed ID: 2475246 [TBL] [Abstract][Full Text] [Related]
16. Characterization of a lipophilic antifolate resistance provoked by treatment of mammalian cells with the antiparasitic agent pyrimethamine. Assaraf YG; Slotky JI J Biol Chem; 1993 Feb; 268(6):4556-66. PubMed ID: 8440739 [TBL] [Abstract][Full Text] [Related]
17. Cross resistance of pleiotropically drug resistant P338 leukemia cells to the lipophilic antifolates trimetrexate and BW 301U. Klohs WD; Steinkampf RW; Besserer JA; Fry DW Cancer Lett; 1986 Jun; 31(3):253-60. PubMed ID: 2941142 [TBL] [Abstract][Full Text] [Related]
18. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells. Matherly LH; Barlowe CK; Goldman ID Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428 [TBL] [Abstract][Full Text] [Related]
19. Expression of variant dihydrofolate reductase with decreased binding affinity to antifolates in MOLT-3 human leukemia cell lines resistant to trimetrexate. Miyachi H; Takemura Y; Kobayashi H; Ando Y Cancer Lett; 1995 Jan; 88(1):93-9. PubMed ID: 7850779 [TBL] [Abstract][Full Text] [Related]
20. Carboxypeptidase G2 enhances trimetrexate cytotoxicity in CCRF-CEM cell lines sensitive and resistant to methotrexate. Romanini A; Chou TC; Bertino JR Adv Enzyme Regul; 1989; 28():323-33. PubMed ID: 2533849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]